pageInfo({
    time : "1261588494290"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "UST11293120080302"
	        , headline : "Eisai's acid reflux drug gets US priority review"
	        , keywords : "[Pharmaceuticals - generic and speciality, Pharmaceuticals (sub-industry), Japan, Asia, Pharmaceuticals - diversified, United Kingdom, Western Europe, Europe, United States of America, Healthcare, Pharmaceuticals and biotechnology, Regulation and enforcement, Economic news, EC, business/financial pages]"
	        , tickers : "[4502.T, gb;AZND, gb;AZNX, gb;TKC, JNJ.N, jp;4502, jp;4523, mx;ABT, mx;WYE, us;ABT, us;AZN, us;AZNC, us;AZND, us;ESAL, us;JNJ, us;WYE, gb;AZN, gb;ABT, ABT.N, AZN.L, de;AHP, de;AHPF, de;AHPS, de;AHPX, de;EII, de;EIIF, de;EIIS, de;EIIX, de;TKD, de;TKDF, de;TKDS, de;TKDX, WYE.N, 4523.T]"
	    }
	    , channel : {
	        id : "1113"
	        , name : "rbssHealthcareNews"
	        , title : "Healthcare"
	    }})